Skip to main content
AmigoFish

ESMO 2026 Breast Cancer Highlights: NATALEE, postMONARCH, TROPION-Breast02, INSPIRE-LM

From Oncology Brothers: Practice-Changing Cancer Discussions · · 24 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

Join us as we discussed the practice changing/informing studies presented at ESMO 2026. In this episode, we welcomed Dr. Javier Cortés, from Spain to discuss 4 key studies that are shaping the future of breast cancer treatment.

Episode Highlights:

- NATALEE: An update on adjuvant ribociclib for T2N0 with high-risk features and node-positive disease, including its impact on overall survival (OS) and distant disease-free survival (DDFS)

- postMONARCH: Insights into the use of abemaciclib after prior CDK4/6 inhibitors in metastatic hormone receptor–positive breast cancer, focusing on progression-free survival (PFS) and OS outcomes

- TROPION-Breast02: A look at the TNBC, highlighting the efficacy of datopotamab deruxtecan (Dato-DXd) in patients with central nervous system (CNS) metastasis

- INSPIRE-LM: Exploring the promising results of intrathecal trastuzumab and pertuzumab for patients with leptomeningeal disease in HER2-positive metastatic breast cancer

Tune in for an in-depth discussion on the latest advancements in breast cancer treatment and how these findings can be integrated into clinical practice.

Listen us on:

Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o

Follow us on social media:

- X/Twitter: https://x.com/oncbrothers

- Instagram: https://www.instagram.com/oncbrothers

- Website: https://oncbrothers.com/

Don't forget to like, subscribe, and hit the notification bell for more updates from the Oncology Brothers!

#BreastCancer, #ESMO2026, #CDK4-6i, #ADC, #OncologyBrothers

Back to Oncology Brothers: Practice-Changing Cancer Discussions · Report a problem